BUY MBP RABIES VACCINE BERIRAB-P 300IU 2ML BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Berirab-P 300 IU is a human rabies immunoglobulin (HRIG) used for post-exposure prophylaxis against rabies. It provides immediate passive immunity to people who may have been exposed to the rabies virus, especially through animal bites, scratches, or contact with saliva on broken skin or mucous membranes.

Rabies is a fatal viral infection once symptoms appear, so immediate treatment after exposure is critical. Berirab-P provides ready-made antibodies that neutralize the virus at the site of entry before the body has time to produce its own immune response.

Berirab-P is always used together with the rabies vaccine, not as a replacement. The immunoglobulin gives immediate short-term protection, while the vaccine helps the body develop long-term immunity.

Berirab-P is given once only, at the start of rabies post-exposure treatment (usually on day 0). The recommended dose is 20 IU per kilogram of body weight. As much of the dose as possible is infiltrated directly into and around the wound, and any remaining volume is injected intramuscularly at a site distant from the vaccine injection (for example, opposite thigh or arm).

It should never be leading to be mixed in the same syringe or injected into the same site as the rabies vaccine, as this can reduce vaccine effectiveness.

Berirab-P works by binding to and neutralizing the rabies virus at the site of entry before it can spread to the nervous system. This is critical because once symptoms of rabies begin, the disease is almost always fatal.

Common side effects include pain, swelling, or redness at the injection site, mild fever, headache, or muscle aches. These are usually mild and temporary. Allergic reactions are rare but may include rash, itching, swelling of the face or throat, dizziness, or difficulty breathing, and require immediate medical attention.

Because Berirab-P is made from human plasma, it undergoes strict screening and viral inactivation processes to ensure safety. The risk of transmitting infections is extremely low.

Berirab-P is considered safe for use in children, pregnant women, and breastfeeding mothers when exposure to rabies has occurred, as the risk of rabies far outweighs any potential risk from the injection.

People who have previously completed a full rabies vaccination course usually do not require immunoglobulin again, only booster doses of the vaccine.

In summary, Berirab-P 300 IU is a life-saving medication used in rabies exposure to provide immediate protection while the body builds its own immune response through vaccination. Prompt administration, proper wound care, and completion of the full rabies vaccination schedule are essential to prevent rabies infection.